Doctor, Deputy Chief Executive Officer (Strategic Partnerships) & Senior Consultant, National Cancer Centre Singapore
Dr Toh is Senior Consultant and Deputy Chief Executive Officer (Strategic Partnerships) in the Division of Medical Oncology at the National Cancer Centre Singapore. He graduated from the University of London, UK with an intercalated Bachelor of Science in ‘Infection and Immunity’ from St Mary’s Hospital Medical School and qualified as a doctor from the University of Cambridge, UK. Dr Toh obtained his Fellowship of the Royal College of Physicians in 2003. He received his medical oncology fellowship training at the Singapore General Hospital, Massachusetts General Hospital, Harvard Medical School, Boston USA, and at the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USA. Dr Toh is alumni at the Harvard Business School General Management Program. He received the National Senior Clinician Scientist Award in 2017 and National Medical Excellence Award (NMEA) in 2018 for his pioneering work in cell and immunotherapy for cancer. Dr Toh leads the NMRC LCG VICTORY (Virus-Induced Cancers Translational Oncology and immunology) grant.
Dr Toh is a Professor and College Master at the Duke-NUS Graduate Medical School. He is founder chairman of the Singapore Society of Oncology Cancer Immunotherapy Consortium, co-founder of the Asia Pacific Gastroenterology Cancer Summit (APGCS), and faculty in Cancer Immunology for the European Society of Medical Oncology (ESMO). Dr Toh has published over 132 peer review journal papers to date.